BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 34702300)

  • 1. Cytotoxic lymphocytes-related gene ITK from a systematic CRISPR screen could predict prognosis of ovarian cancer patients with distant metastasis.
    Xu M; Huang S; Chen J; Xu W; Xiang R; Piao Y; Zhao S
    J Transl Med; 2021 Oct; 19(1):447. PubMed ID: 34702300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Novel Immune and Stroma Related Prognostic Marker for Invasive Breast Cancer in Tumor Microenvironment: A TCGA Based Study.
    Huang Y; Chen L; Tang Z; Min Y; Yu W; Yang G; Zhang L
    Front Endocrinol (Lausanne); 2021; 12():774244. PubMed ID: 34867821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hierarchy of signaling thresholds downstream of the T cell receptor and the Tec kinase ITK.
    Gallagher MP; Conley JM; Vangala P; Garber M; Reboldi A; Berg LJ
    Proc Natl Acad Sci U S A; 2021 Aug; 118(35):. PubMed ID: 34452995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of metastasis and prognosis-associated genes for serous ovarian cancer.
    Yang Y; Qi S; Shi C; Han X; Yu J; Zhang L; Qin S; Gao Y
    Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32510146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome-wide CRISPR/Cas9 library screen identifies PCMT1 as a critical driver of ovarian cancer metastasis.
    Zhang J; Li Y; Liu H; Zhang J; Wang J; Xia J; Zhang Y; Yu X; Ma J; Huang M; Wang J; Wang L; Li Q; Cui R; Yang W; Xu Y; Feng W
    J Exp Clin Cancer Res; 2022 Jan; 41(1):24. PubMed ID: 35033172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Construction of Competitive Endogenous RNA Network and Verification of 3-Key LncRNA Signature Associated With Distant Metastasis and Poor Prognosis in Patients With Clear Cell Renal Cell Carcinoma.
    Su Y; Zhang T; Tang J; Zhang L; Fan S; Zhou J; Liang C
    Front Oncol; 2021; 11():640150. PubMed ID: 33869028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Itk-mediated integration of T cell receptor and cytokine signaling regulates the balance between Th17 and regulatory T cells.
    Gomez-Rodriguez J; Wohlfert EA; Handon R; Meylan F; Wu JZ; Anderson SM; Kirby MR; Belkaid Y; Schwartzberg PL
    J Exp Med; 2014 Mar; 211(3):529-43. PubMed ID: 24534190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downregulated Long Noncoding RNA DGCR5 Acts as a New Promising Biomarker for the Diagnosis and Prognosis of Ovarian Cancer.
    Chen H; Tian X; Luan Y; Lu H
    Technol Cancer Res Treat; 2019; 18():1533033819896809. PubMed ID: 31868103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Signaling of the ITK (interleukin 2-inducible T cell kinase)-SYK (spleen tyrosine kinase) fusion kinase is dependent on adapter SLP-76 and on the adapter function of the kinases SYK and ZAP70.
    Hussain A; Mohammad DK; Gustafsson MO; Uslu M; Hamasy A; Nore BF; Mohamed AJ; Smith CI
    J Biol Chem; 2013 Mar; 288(10):7338-50. PubMed ID: 23293025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of a novel interaction between transcription factor TFII-I and the inducible tyrosine kinase in T cells.
    Sacristán C; Schattgen SA; Berg LJ; Bunnell SC; Roy AL; Rosenstein Y
    Eur J Immunol; 2009 Sep; 39(9):2584-95. PubMed ID: 19701889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High α B-crystallin and p53 co-expression is associated with poor prognosis in ovarian cancer.
    Tan L; Sha L; Hou N; Zhang M; Ma Q; Shi C
    Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31152111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prognostic model based on immune-related long noncoding RNAs for patients with epithelial ovarian cancer.
    Peng Y; Wang H; Huang Q; Wu J; Zhang M
    J Ovarian Res; 2022 Jan; 15(1):8. PubMed ID: 35031063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential regulation of human NK cell-mediated cytotoxicity by the tyrosine kinase Itk.
    Khurana D; Arneson LN; Schoon RA; Dick CJ; Leibson PJ
    J Immunol; 2007 Mar; 178(6):3575-82. PubMed ID: 17339454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. itk, a T-cell-specific tyrosine kinase gene inducible by interleukin 2.
    Siliciano JD; Morrow TA; Desiderio SV
    Proc Natl Acad Sci U S A; 1992 Dec; 89(23):11194-8. PubMed ID: 1280821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Five-Gene Expression Signature Predicts Ovarian Cancer Metastasis.
    Gu Y; Zhang S
    Crit Rev Eukaryot Gene Expr; 2021; 31(5):41-50. PubMed ID: 34591389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pretransplant Short-Term Exposure of Donor Graft Cells to ITK Selective Inhibitor Ameliorates Acute Graft-versus-Host Disease by Inhibiting Effector T Cell Differentiation while Sparing Regulatory T Cells.
    Kondo T; Ikegawa S; Fukumi T; Sumii Y; Sugiura H; Sando Y; Nakamura M; Meguri Y; Iwamoto M; Maeda Y; Matsuoka KI
    Immunohorizons; 2021 Jun; 5(6):424-437. PubMed ID: 34112701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficient CD28 signalling leads to increases in the kinase activities of the TEC family tyrosine kinase EMT/ITK/TSK and the SRC family tyrosine kinase LCK.
    Gibson S; Truitt K; Lu Y; Lapushin R; Khan H; Imboden JB; Mills GB
    Biochem J; 1998 Mar; 330 ( Pt 3)(Pt 3):1123-8. PubMed ID: 9494076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Localization of the human IL-2-inducible T-cell kinase gene (ITK) to chromosome band 5q34 and the mouse gene (Itk) to chromosome 15 by fluorescence in situ hybridization.
    Tate G; Okuyama M; Okamoto M; Futaki G; Kimura S; Endo Y; Mitsuya T; Katagiri M
    Cytogenet Cell Genet; 1996; 74(1-2):96-8. PubMed ID: 8893810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Translocation-generated ITK-FER and ITK-SYK fusions induce STAT3 phosphorylation and CD69 expression.
    Fathi NN; Mohammad DK; Görgens A; Andaloussi SE; Zain R; Nore BF; Smith CIE
    Biochem Biophys Res Commun; 2018 Oct; 504(4):749-752. PubMed ID: 30217447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD44 Variant 6 as a Predictive Biomarker for Distant Metastasis in Patients With Epithelial Ovarian Cancer.
    Motohara T; Fujimoto K; Tayama S; Narantuya D; Sakaguchi I; Tashiro H; Katabuchi H
    Obstet Gynecol; 2016 Jun; 127(6):1003-1011. PubMed ID: 27159753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.